Krebs Biochemicals & Industries Limited (BOM:524518)
India · Delayed Price · Currency is INR 60.17
-1.83 (-2.95%)
At close: Jan 20, 2026
BOM:524518 Revenue
Krebs Biochemicals & Industries had revenue of 41.67M INR in the quarter ending September 30, 2025, a decrease of -67.58%. This brings the company's revenue in the last twelve months to 272.16M, down -46.31% year-over-year. In the fiscal year ending March 31, 2025, Krebs Biochemicals & Industries had annual revenue of 433.12M, down -14.10%.
Revenue (ttm)
272.16M
Revenue Growth
-46.31%
P/S Ratio
5.03
Revenue / Employee
1.35M
Employees
202
Market Cap
1.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 433.12M | -71.10M | -14.10% |
| Mar 31, 2024 | 504.22M | -17.13M | -3.29% |
| Mar 31, 2023 | 521.34M | -75.69M | -12.68% |
| Mar 31, 2022 | 597.03M | 70.20M | 13.32% |
| Mar 31, 2021 | 526.84M | 202.88M | 62.63% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aarey Drugs & Pharmaceuticals | 4.28B |
| Infinium Pharmachem | 1.57B |
| Kimia Biosciences | 1.26B |
| Influx Healthtech | 1.24B |
| Smruthi Organics | 1.20B |
| Panchsheel Organics | 1.03B |
| Resonance Specialties | 852.48M |
| Tyche Industries | 570.25M |
Krebs Biochemicals & Industries News
- 1 year ago - Krebs Biochemicals & Industries halts production following order from Andhra Pradesh Pollution Control Board - Business Upturn